These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 24242074)

  • 41. Treatment of mitochondrial electron transport chain disorders: a review of clinical trials over the past decade.
    Kerr DS
    Mol Genet Metab; 2010 Mar; 99(3):246-55. PubMed ID: 20060349
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Coenzyme Q treatment of neurodegenerative diseases of aging.
    Galpern WR; Cudkowicz ME
    Mitochondrion; 2007 Jun; 7 Suppl():S146-53. PubMed ID: 17485247
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Effects of Coenzyme Q10 Supplementation on Blood Pressures Among Patients with Metabolic Diseases: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Tabrizi R; Akbari M; Sharifi N; Lankarani KB; Moosazadeh M; Kolahdooz F; Taghizadeh M; Asemi Z
    High Blood Press Cardiovasc Prev; 2018 Mar; 25(1):41-50. PubMed ID: 29330704
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Beneficial effects of creatine, CoQ10, and lipoic acid in mitochondrial disorders.
    Rodriguez MC; MacDonald JR; Mahoney DJ; Parise G; Beal MF; Tarnopolsky MA
    Muscle Nerve; 2007 Feb; 35(2):235-42. PubMed ID: 17080429
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effects of coenzyme Q10 supplementation on biomarkers of inflammation and oxidative stress in among coronary artery disease: a systematic review and meta-analysis of randomized controlled trials.
    Jorat MV; Tabrizi R; Kolahdooz F; Akbari M; Salami M; Heydari ST; Asemi Z
    Inflammopharmacology; 2019 Apr; 27(2):233-248. PubMed ID: 30758695
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Coenzyme Q10 and neuropsychiatric and neurological disorders: relevance for schizophrenia.
    Maguire Á; Hargreaves A; Gill M
    Nutr Neurosci; 2020 Oct; 23(10):756-769. PubMed ID: 30537908
    [No Abstract]   [Full Text] [Related]  

  • 47. A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit.
    ; Beal MF; Oakes D; Shoulson I; Henchcliffe C; Galpern WR; Haas R; Juncos JL; Nutt JG; Voss TS; Ravina B; Shults CM; Helles K; Snively V; Lew MF; Griebner B; Watts A; Gao S; Pourcher E; Bond L; Kompoliti K; Agarwal P; Sia C; Jog M; Cole L; Sultana M; Kurlan R; Richard I; Deeley C; Waters CH; Figueroa A; Arkun A; Brodsky M; Ondo WG; Hunter CB; Jimenez-Shahed J; Palao A; Miyasaki JM; So J; Tetrud J; Reys L; Smith K; Singer C; Blenke A; Russell DS; Cotto C; Friedman JH; Lannon M; Zhang L; Drasby E; Kumar R; Subramanian T; Ford DS; Grimes DA; Cote D; Conway J; Siderowf AD; Evatt ML; Sommerfeld B; Lieberman AN; Okun MS; Rodriguez RL; Merritt S; Swartz CL; Martin WR; King P; Stover N; Guthrie S; Watts RL; Ahmed A; Fernandez HH; Winters A; Mari Z; Dawson TM; Dunlop B; Feigin AS; Shannon B; Nirenberg MJ; Ogg M; Ellias SA; Thomas CA; Frei K; Bodis-Wollner I; Glazman S; Mayer T; Hauser RA; Pahwa R; Langhammer A; Ranawaya R; Derwent L; Sethi KD; Farrow B; Prakash R; Litvan I; Robinson A; Sahay A; Gartner M; Hinson VK; Markind S; Pelikan M; Perlmutter JS; Hartlein J; Molho E; Evans S; Adler CH; Duffy A; Lind M; Elmer L; Davis K; Spears J; Wilson S; Leehey MA; Hermanowicz N; Niswonger S; Shill HA; Obradov S; Rajput A; Cowper M; Lessig S; Song D; Fontaine D; Zadikoff C; Williams K; Blindauer KA; Bergholte J; Propsom CS; Stacy MA; Field J; Mihaila D; Chilton M; Uc EY; Sieren J; Simon DK; Kraics L; Silver A; Boyd JT; Hamill RW; Ingvoldstad C; Young J; Thomas K; Kostyk SK; Wojcieszek J; Pfeiffer RF; Panisset M; Beland M; Reich SG; Cines M; Zappala N; Rivest J; Zweig R; Lumina LP; Hilliard CL; Grill S; Kellermann M; Tuite P; Rolandelli S; Kang UJ; Young J; Rao J; Cook MM; Severt L; Boyar K
    JAMA Neurol; 2014 May; 71(5):543-52. PubMed ID: 24664227
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of coenzyme Q10 on statin-induced myopathy: a meta-analysis of randomized controlled trials.
    Banach M; Serban C; Sahebkar A; Ursoniu S; Rysz J; Muntner P; Toth PP; Jones SR; Rizzo M; Glasser SP; Lip GY; Dragan S; Mikhailidis DP;
    Mayo Clin Proc; 2015 Jan; 90(1):24-34. PubMed ID: 25440725
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Border between natural product and drug: comparison of the related benzoquinones idebenone and coenzyme Q10.
    Gueven N; Woolley K; Smith J
    Redox Biol; 2015; 4():289-95. PubMed ID: 25625583
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effects of coenzyme Q10 supplementation on lipid profiles among patients with coronary artery disease: a systematic review and meta-analysis of randomized controlled trials.
    Jorat MV; Tabrizi R; Mirhosseini N; Lankarani KB; Akbari M; Heydari ST; Mottaghi R; Asemi Z
    Lipids Health Dis; 2018 Oct; 17(1):230. PubMed ID: 30296936
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mechanism of the neuroprotective role of coenzyme Q10 with or without L-dopa in rotenone-induced parkinsonism.
    Abdin AA; Hamouda HE
    Neuropharmacology; 2008 Dec; 55(8):1340-6. PubMed ID: 18817789
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Coenzyme Q10 for Patients with Parkinson's Disease: A Systematic Review and Meta-Analysis.
    Negida A; Menshawy A; El Ashal G; Elfouly Y; Hani Y; Hegazy Y; El Ghonimy S; Fouda S; Rashad Y
    CNS Neurol Disord Drug Targets; 2016; 15(1):45-53. PubMed ID: 26553164
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Coenzyme Q10 serum levels in Huntington's disease.
    Andrich J; Saft C; Gerlach M; Schneider B; Arz A; Kuhn W; Müller T
    J Neural Transm Suppl; 2004; (68):111-6. PubMed ID: 15354396
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prophylactic treatment with coenzyme Q10 in patients undergoing cardiac surgery: could an antioxidant reduce complications? A systematic review and meta-analysis.
    de Frutos F; Gea A; Hernandez-Estefania R; Rabago G
    Interact Cardiovasc Thorac Surg; 2015 Feb; 20(2):254-9. PubMed ID: 25344142
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Coenzyme Q10 protects astrocytes from ROS-induced damage through inhibition of mitochondria-mediated cell death pathway.
    Jing L; He MT; Chang Y; Mehta SL; He QP; Zhang JZ; Li PA
    Int J Biol Sci; 2015; 11(1):59-66. PubMed ID: 25552930
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evidence for behavioral benefits of early dietary supplementation with CoEnzymeQ10 in a slowly progressing mouse model of Huntington's disease.
    Hickey MA; Zhu C; Medvedeva V; Franich NR; Levine MS; Chesselet MF
    Mol Cell Neurosci; 2012 Feb; 49(2):149-57. PubMed ID: 22044764
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effectiveness of creatine treatment for Parkinson's disease: an updated meta-analysis of randomized controlled trials.
    Mo JJ; Liu LY; Peng WB; Rao J; Liu Z; Cui LL
    BMC Neurol; 2017 Jun; 17(1):105. PubMed ID: 28577542
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of Coenzyme Q10 supplementation on mitochondrial electron transport chain activity and mitochondrial oxidative stress in Coenzyme Q10 deficient human neuronal cells.
    Duberley KE; Heales SJ; Abramov AY; Chalasani A; Land JM; Rahman S; Hargreaves IP
    Int J Biochem Cell Biol; 2014 May; 50():60-3. PubMed ID: 24534273
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antioxidants and other pharmacological treatments for Friedreich ataxia.
    Kearney M; Orrell RW; Fahey M; Pandolfo M
    Cochrane Database Syst Rev; 2012 Apr; (4):CD007791. PubMed ID: 22513953
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Coenzyme Q10 in Parkinson's disease. Symptomatic or neuroprotective effects?].
    Storch A
    Nervenarzt; 2007 Dec; 78(12):1378-82. PubMed ID: 17508194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.